Tagged: cell therapy

Good Exit: Crowdfunded Company Celixir Delivers 2.7X Returns for Early Shareholders in Buy-Back Offer

Biotech company Celixir has initiated a share-back for early investors. The company is offering shareholders a 2.7x return if they accept the offer. According to the company, 18% of Celixir shareholders have decided to accept the offer with the remaining holding their shares with the… Read More

Brief: Crowdcube Success Cell Therapy Receives £12.5M in Japan Rights Deal

On Tuesday, Crowdcube #FundedClub member, Cell Therapy (CTL), announced it has received £12.5M in a Japan Rights Deal. The Welsh biotech company, co-founded by Nobel Prize winner Sir Martin Evans, raised £689,246 through the equity crowdfunding platform to help cell-based regeneration medicine for heart trauma get to… Read More

British Biotech Cell Therapy Successfully Raises Nearly £690,000 For Heart Medication on Crowdcube

Cell Therapy, British biotech company co-founded by Nobel Prize winner Sir Martin Evans, announced that it has raised £689,246 through crowdfunding platform Crowdcube to help cell-based regeneration medicine for heart trauma get to the market. The project’s description reads,”Cell Therapy Limited (CTL) has developed a breakthrough… Read More

Send this to a friend